Evolutionary conflicts between viruses and restriction factors shape immunity

Host restriction factors are potent, widely expressed intracellular blocks to viral replication that are an important component of the innate immune response to viral infection. However, viruses have evolved mechanisms that antagonize restriction factors. Through evolutionary pressure for both host survival and virus replication, an evolutionary 'arms race' has developed that drives continuous rounds of selection for beneficial mutations in the genes encoding restriction factors and their viral antagonists. Because viruses can evolve faster than their hosts, the innate immune system of modern-day vertebrates is for the most part optimized to defend against ancient viruses, rather than newer viral threats. Thus, the evolutionary history of restriction factors might, in part, explain why humans are susceptible or resistant to the viruses present in the modern world.

[1]  A. Takaoka,et al.  Interferon signalling network in innate defence , 2006, Cellular microbiology.

[2]  G. Learn,et al.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. , 2009, Cell host & microbe.

[3]  S. O’Brien,et al.  Functions, structure, and read-through alternative splicing of feline APOBEC3 genes , 2008, Genome Biology.

[4]  S. Tishkoff,et al.  Evidence for balancing selection from nucleotide sequence analyses of human G6PD. , 2002, American journal of human genetics.

[5]  M. Emerman,et al.  An expanded clade of rodent Trim5 genes. , 2009, Virology.

[6]  F. Kirchhoff,et al.  HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef , 2011, Retrovirology.

[7]  F. Bonhomme,et al.  Molecular phylogeny of Fv1 , 1998, Mammalian Genome.

[8]  B. Cullen,et al.  Equine Infectious Anemia Virus Resists the Antiretroviral Activity of Equine APOBEC3 Proteins through a Packaging-Independent Mechanism , 2008, Journal of Virology.

[9]  S. Sawyer,et al.  Molecular evolution of the antiretroviral TRIM5 gene , 2009, Immunogenetics.

[10]  J. M. Cameron,et al.  Inhibition of PKR by RNA and DNA viruses. , 2006, Virus research.

[11]  S. Neil,et al.  Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction , 2011, Viruses.

[12]  M. Emerman,et al.  Paleovirology—Modern Consequences of Ancient Viruses , 2010, PLoS biology.

[13]  Michael Emerman,et al.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Shiu-Lok Hu,et al.  TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis , 2008, Proceedings of the National Academy of Sciences.

[15]  A. Geballe,et al.  Essential Role for either TRS1 or IRS1 in Human Cytomegalovirus Replication , 2009, Journal of Virology.

[16]  R. Nielsen Molecular signatures of natural selection. , 2005, Annual review of genetics.

[17]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[18]  Jun Wang,et al.  Small-Molecule Inhibition of TNF-α , 2005, Science.

[19]  J. Heeney,et al.  Independent evolution of an antiviral TRIMCyp in rhesus macaques , 2008, Proceedings of the National Academy of Sciences.

[20]  V. Chow,et al.  In vivo and in vitro studies on the antiviral activities of viperin against influenza H1N1 virus infection. , 2012, The Journal of general virology.

[21]  P. Bieniasz,et al.  Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion , 2006, Science.

[22]  Ruchi M. Newman,et al.  TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species , 2010, PLoS biology.

[23]  J. Luban,et al.  Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 , 2004, Nature.

[24]  Nels C. Elde,et al.  Protein kinase R reveals an evolutionary model for defeating viral mimicry , 2008, Nature.

[25]  B. Su,et al.  A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection , 2007, AIDS.

[26]  Xianghui Yu,et al.  Differential Requirement for Conserved Tryptophans in Human Immunodeficiency Virus Type 1 Vif for the Selective Suppression of APOBEC3G and APOBEC3F , 2006, Journal of Virology.

[27]  M. Emerman,et al.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition. , 2011, Virology.

[28]  Michael Emerman,et al.  Positive Selection and Increased Antiviral Activity Associated with the PARP-Containing Isoform of Human Zinc-Finger Antiviral Protein , 2008, PLoS genetics.

[29]  J. Sodroski,et al.  Hexagonal assembly of a restricting TRIM5α protein , 2010, Proceedings of the National Academy of Sciences.

[30]  P. Sharp,et al.  Gene acquisition in HIV and SIV , 1996, Nature.

[31]  S. Ross,et al.  Expression of Murine APOBEC3 Alleles in Different Mouse Strains and Their Effect on Mouse Mammary Tumor Virus Infection , 2009, Journal of Virology.

[32]  Yunkai Yu,et al.  Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.

[33]  T. Heidmann,et al.  Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.

[34]  Michael Gale,et al.  Recognition of viruses by cytoplasmic sensors. , 2010, Current opinion in immunology.

[35]  D. Stetson,et al.  Connections between antiviral defense and autoimmunity. , 2009, Current opinion in immunology.

[36]  T. Gojobori,et al.  A Large Variation in the Rates of Synonymous Substitution for RNA Viruses and Its Relationship to a Diversity of Viral Infection and Transmission Modes , 2004, Molecular biology and evolution.

[37]  Or Zuk,et al.  A Composite of Multiple Signals Distinguishes Causal Variants in Regions of Positive Selection , 2010, Science.

[38]  B. Peterlin,et al.  APOBEC3 inhibits mouse mammary tumour virus replication in vivo , 2007, Nature.

[39]  Paul Kellam,et al.  IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.

[40]  Frédéric Delsuc,et al.  Evolutionary and Functional Analyses of the Interaction between the Myeloid Restriction Factor SAMHD1 and the Lentiviral Vpx Protein , 2012 .

[41]  M. Emerman,et al.  Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H , 2006, Journal of Virology.

[42]  P. Bieniasz,et al.  Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species , 2008, Proceedings of the National Academy of Sciences.

[43]  Jeremy Luban,et al.  TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.

[44]  Shameek Biswas,et al.  Genomic insights into positive selection. , 2006, Trends in genetics : TIG.

[45]  Hong Cao,et al.  Small-molecule inhibition of HIV-1 Vif , 2008, Nature Biotechnology.

[46]  D. Douek,et al.  Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts , 2009, Nature Medicine.

[47]  J. Goncalves,et al.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. , 2004, Genes & development.

[48]  W. Brown,et al.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction , 2010, Nucleic acids research.

[49]  Edward C Holmes,et al.  High rate of viral evolution associated with the emergence of carnivore parvovirus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Edward C Holmes,et al.  Error thresholds and the constraints to RNA virus evolution , 2003, Trends in Microbiology.

[51]  Baek Kim,et al.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.

[52]  Michael Emerman,et al.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.

[53]  M. Emerman,et al.  Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G , 2004, PLoS biology.

[54]  Jian-Dong Jiang,et al.  Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G* , 2010, The Journal of Biological Chemistry.

[55]  M. Colonna,et al.  Cutting Edge: Paradoxical Roles of BST2/Tetherin in Promoting Type I IFN Response and Viral Infection , 2012, The Journal of Immunology.

[56]  T. Gojobori,et al.  A Large Variation in the Rates of Synonymous Substitution for RNA Viruses and Its Relationship to a Diversity of Viral Infection and Transmission Modes , 2004, Molecular Biology and Evolution.

[57]  E. Holmes,et al.  Phylogenetic Evidence for the Rapid Evolution of Human B19 Erythrovirus , 2006, Journal of Virology.

[58]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[59]  P. Bieniasz,et al.  Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo , 2011, Proceedings of the National Academy of Sciences.

[60]  O. Pybus,et al.  The evolutionary dynamics of endogenous retroviruses. , 2005, Trends in microbiology.

[61]  S. Goff,et al.  Host restriction factors blocking retroviral replication. , 2008, Annual review of genetics.

[62]  Michael Emerman,et al.  Discordant Evolution of the Adjacent Antiretroviral Genes TRIM22 and TRIM5 in Mammals , 2007, PLoS pathogens.

[63]  T. Pincus,et al.  A MAJOR GENETIC LOCUS AFFECTING RESISTANCE TO INFECTION WITH MURINE LEUKEMIA VIRUSES , 1971, The Journal of experimental medicine.

[64]  D. Ho,et al.  Natural Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification , 2005, PLoS pathogens.

[65]  M. Emerman,et al.  Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. , 2008, Cell host & microbe.

[66]  V. Pathak,et al.  Identification of Two Distinct Human Immunodeficiency Virus Type 1 Vif Determinants Critical for Interactions with Human APOBEC3G and APOBEC3F , 2007, Journal of Virology.

[67]  M. Worobey,et al.  An Endogenous Foamy-like Viral Element in the Coelacanth Genome , 2012, PLoS pathogens.

[68]  M. Malim,et al.  Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets , 2009, Journal of Virology.

[69]  M. Emerman,et al.  The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. , 2012, Cell host & microbe.

[70]  C. Feschotte,et al.  Parallel Germline Infiltration of a Lentivirus in Two Malagasy Lemurs , 2009, PLoS genetics.

[71]  Michael Emerman,et al.  Ancient Adaptive Evolution of Tetherin Shaped the Functions of Vpu and Nef in Human Immunodeficiency Virus and Primate Lentiviruses , 2010, Journal of Virology.

[72]  Nels C. Elde,et al.  The evolutionary conundrum of pathogen mimicry , 2009, Nature Reviews Microbiology.

[73]  M. Neuberger,et al.  Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. , 2005, Molecular biology and evolution.

[74]  Michael Emerman,et al.  The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. , 2012, Cell host & microbe.

[75]  P. Sharp,et al.  Origins of HIV and the AIDS pandemic. , 2011, Cold Spring Harbor perspectives in medicine.

[76]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[77]  M. Linial,et al.  Historical Perspective of Foamy Virus Epidemiology and Infection , 2001, Clinical Microbiology Reviews.

[78]  Ruchi M. Newman,et al.  Evolution of a TRIM5-CypA Splice Isoform in Old World Monkeys , 2008, PLoS pathogens.

[79]  R. Nielsen,et al.  Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. , 1998, Genetics.

[80]  R. Shafer,et al.  A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution , 2008, Proceedings of the National Academy of Sciences.

[81]  J. Sutcliffe,et al.  Identification of a second interferon-regulated murine Mx gene , 1988, Molecular and cellular biology.

[82]  U. Certa,et al.  The small interferon-induced transmembrane genes and proteins. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[83]  Quan Zhang,et al.  High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2. , 2011, Antiviral research.

[84]  A. Clark,et al.  Recent and ongoing selection in the human genome , 2007, Nature Reviews Genetics.

[85]  Joanna L. Kelley,et al.  Positive selection in the human genome: from genome scans to biological significance. , 2008, Annual review of genomics and human genetics.

[86]  P. Bieniasz,et al.  Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants , 2009, PLoS pathogens.

[87]  G. Cheng,et al.  New developments in the induction and antiviral effectors of type I interferon. , 2011, Current opinion in immunology.

[88]  Jonathan C. Fuller,et al.  Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response , 2009, Nature Genetics.

[89]  M. Emerman,et al.  The function and evolution of the restriction factor viperin in primates was not driven by lentiviruses , 2012, Retrovirology.

[90]  L. V. Valen,et al.  A new evolutionary law , 1973 .

[91]  M. Emerman,et al.  The Breadth of Antiviral Activity of Apobec3DE in Chimpanzees Has Been Driven by Positive Selection , 2011, Journal of Virology.

[92]  W. Heneine,et al.  Ancient co-speciation of simian foamy viruses and primates , 2005, Nature.

[93]  O. Haller,et al.  Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. , 1987, Journal of interferon research.

[94]  Joseph K. Pickrell,et al.  The Genetics of Human Adaptation: Hard Sweeps, Soft Sweeps, and Polygenic Adaptation , 2010, Current Biology.

[95]  A. Katzourakis,et al.  Endogenous Viral Elements in Animal Genomes , 2010, PLoS genetics.

[96]  S. Neil,et al.  A Cytoplasmic Tail Determinant in HIV-1 Vpu Mediates Targeting of Tetherin for Endosomal Degradation and Counteracts Interferon-Induced Restriction , 2012, PLoS pathogens.

[97]  Ruchi M. Newman,et al.  Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α , 2006, Proceedings of the National Academy of Sciences.

[98]  John S. Albin,et al.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics , 2010, Expert Reviews in Molecular Medicine.

[99]  S. Sugano,et al.  Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways , 2003, Oncogene.

[100]  T. Yamashita,et al.  Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells , 2006, Proceedings of the National Academy of Sciences.

[101]  F. Kirchhoff Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. , 2010, Cell host & microbe.

[102]  Timothy P. L. Smith,et al.  The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals , 2008, BMC Molecular Biology.

[103]  M. Santiago,et al.  A Single Nucleotide Polymorphism in Tetherin Promotes Retrovirus Restriction In Vivo , 2012, PLoS pathogens.

[104]  Edward C. Holmes,et al.  Rates of Molecular Evolution in RNA Viruses: A Quantitative Phylogenetic Analysis , 2002, Journal of Molecular Evolution.

[105]  M. Malim,et al.  Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.

[106]  A. Hughes,et al.  Natural selection at major histocompatibility complex loci of vertebrates. , 1998, Annual review of genetics.